VRDN: FDA Approves Lumvoa
Viridian Therapeutics receives FDA approval for Lumvoa to treat thyroid eye disease and plans to launch immediately
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.